Halıt Karaca
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 25
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 4
-
- Gastric Cancer Management and Outcomes 7
- Renal cell carcinoma treatment 5
- Co-authors
- Velı Berk (18 shared papers)Nihat Kalay (3 shared papers)Ali Ergin (2 shared papers)Mahmut Akpek (3 shared papers)Metin Özkan (5 shared papers)Mustafa Dikilitaş (7 shared papers)Metin Özkan (24 shared papers)Ersin Özaslan (11 shared papers)
In The Last Decade
Halıt Karaca
50 papers receiving 818 citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 373
- Oncology 422
- Pulmonary and Respiratory Medicine 275
- Gastroenterology 25
- Radiology, Nuclear Medicine and Imaging 94
Countries citing papers authored by Halıt Karaca
This map shows the geographic impact of Halıt Karaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halıt Karaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halıt Karaca more than expected).
Fields of papers citing papers by Halıt Karaca
This network shows the impact of papers produced by Halıt Karaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halıt Karaca. The network helps show where Halıt Karaca may publish in the future.
Co-authors
The 25 scholars most cited alongside Halıt Karaca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 222 | |
| 2 | 2014 | 162 | |
| 3 | 2004 | 70 | |
| 4 | 2013 | 51 | |
| 5 | 2011 | 30 | |
| 6 | 2015 | 22 | |
| 7 | 2014 | 17 | |
| 8 | 2015 | 16 | |
| 9 | Co-existence of gastrointestinal stromal tumors with other primary neoplasms. | 2011 | 15 |
| 10 | 2015 | 14 | |
| 11 | 2010 | 14 | |
| 12 | 2012 | 13 | |
| 13 | 2012 | 12 | |
| 14 | 2016 | 12 | |
| 15 | 2009 | 10 | |
| 16 | 2016 | 9 | |
| 17 | 2012 | 9 | |
| 18 | 2013 | 9 | |
| 19 | 2014 | 8 | |
| 20 | 2016 | 8 |
About Halıt Karaca
Halıt Karaca is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Cancer Research and Surgery, having authored 52 papers that have together received 839 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Cancer Treatment and Pharmacology (5 papers), Renal cell carcinoma treatment (5 papers), Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (373 citations), Oncology (422 citations), Pulmonary and Respiratory Medicine (275 citations), Gastroenterology (25 citations) and Radiology, Nuclear Medicine and Imaging (94 citations). Halıt Karaca has collaborated with scholars based in Türkiye, Belgium and Hong Kong. Frequent co-authors include Velı Berk, Nihat Kalay, Ali Ergin, Mahmut Akpek, Metin Özkan, Mustafa Dikilitaş, Metin Özkan, Ersin Özaslan, Mevlüde İnanç and Mehmet Güngör Kaya. Their work appears in journals such as Medical Oncology, Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology, International Journal of Cardiology and Journal of Endourology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.